224 related articles for article (PubMed ID: 37333824)
1. Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer.
Liu M; Sui L; Fang Z; Jiang WG; Ye L
Front Oncol; 2023; 13():1166955. PubMed ID: 37333824
[TBL] [Abstract][Full Text] [Related]
2. Deregulated bone morphogenetic proteins and their receptors are associated with disease progression of gastric cancer.
Sun Z; Liu C; Jiang WG; Ye L
Comput Struct Biotechnol J; 2020; 18():177-188. PubMed ID: 31988704
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.
Takahashi M; Otsuka F; Miyoshi T; Otani H; Goto J; Yamashita M; Ogura T; Makino H; Doihara H
J Endocrinol; 2008 Dec; 199(3):445-55. PubMed ID: 18780779
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.
Alarmo EL; Kuukasjärvi T; Karhu R; Kallioniemi A
Breast Cancer Res Treat; 2007 Jun; 103(2):239-46. PubMed ID: 17004110
[TBL] [Abstract][Full Text] [Related]
5. Changes in expression of bone morphogenetic proteins (BMPs), their receptors and inhibin co-receptor betaglycan during bovine antral follicle development: inhibin can antagonize the suppressive effect of BMPs on thecal androgen production.
Glister C; Satchell L; Knight PG
Reproduction; 2010 Nov; 140(5):699-712. PubMed ID: 20739376
[TBL] [Abstract][Full Text] [Related]
6. BMP signaling pathways affect differently migration and invasion of esophageal squamous cancer cells.
Hu M; Cui F; Liu F; Wang J; Wei X; Li Y
Int J Oncol; 2017 Jan; 50(1):193-202. PubMed ID: 27959431
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study.
Slattery ML; John EM; Torres-Mejia G; Herrick JS; Giuliano AR; Baumgartner KB; Hines LM; Wolff RK
Int J Cancer; 2013 Jun; 132(12):2928-39. PubMed ID: 23180569
[TBL] [Abstract][Full Text] [Related]
8. High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor‑positive breast cancer.
Katsuta E; Maawy AA; Yan L; Takabe K
Oncol Rep; 2019 Oct; 42(4):1413-1421. PubMed ID: 31524275
[TBL] [Abstract][Full Text] [Related]
9. Gremlin, Noggin, Chordin and follistatin differentially modulate BMP induced suppression of androgen secretion by bovine ovarian theca cells.
Glister C; Regan SL; Samir M; Knight P
J Mol Endocrinol; 2018 Oct; ():. PubMed ID: 30400042
[TBL] [Abstract][Full Text] [Related]
10. GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients.
Neckmann U; Wolowczyk C; Hall M; Almaas E; Ren J; Zhao S; Johannessen B; Skotheim RI; Bjørkøy G; Ten Dijke P; Holien T
Cell Commun Signal; 2019 Nov; 17(1):140. PubMed ID: 31694641
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance.
Davies SR; Watkins G; Douglas-Jones A; Mansel RE; Jiang WG
J Exp Ther Oncol; 2008; 7(4):327-38. PubMed ID: 19227012
[TBL] [Abstract][Full Text] [Related]
13. The Dual Role of Bone Morphogenetic Proteins in Cancer.
Bach DH; Park HJ; Lee SK
Mol Ther Oncolytics; 2018 Mar; 8():1-13. PubMed ID: 29234727
[TBL] [Abstract][Full Text] [Related]
14. BMP2, 4 and 6 and BMPR1B are altered from early stages of bovine cystic ovarian disease development.
Díaz PU; Hein GJ; Belotti EM; Rodríguez FM; Rey F; Amweg AN; Matiller V; Baravalle ME; Ortega HH; Salvetti NR
Reproduction; 2016 Oct; 152(4):333-50. PubMed ID: 27486268
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Analysis of the Genetic and Epigenetic Alterations of Bone Morphogenetic Protein Receptors in Metastatic Breast Cancer.
Hermawan A; Putri H
Biochem Genet; 2024 Apr; 62(2):594-620. PubMed ID: 37486509
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.
Guo D; Huang J; Gong J
Mol Cell Biochem; 2012 Apr; 363(1-2):179-90. PubMed ID: 22167620
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins are mediators of luteolysis in the human corpus luteum.
Nio-Kobayashi J; Trendell J; Giakoumelou S; Boswell L; Nicol L; Kudo M; Sakuragi N; Iwanaga T; Duncan WC
Endocrinology; 2015 Apr; 156(4):1494-503. PubMed ID: 25635621
[TBL] [Abstract][Full Text] [Related]
18. Regulation of GNRH production by estrogen and bone morphogenetic proteins in GT1-7 hypothalamic cells.
Otani H; Otsuka F; Takeda M; Mukai T; Terasaka T; Miyoshi T; Inagaki K; Suzuki J; Ogura T; Lawson MA; Makino H
J Endocrinol; 2009 Oct; 203(1):87-97. PubMed ID: 19635757
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors and Survival According to Tumor Subtype in Women With Breast Cancer Brain Metastases.
Lopes S; Vieira I; Abreu M; Pousa I; Ferreira A; Sousa S; Pereira D
Curr Probl Cancer; 2022 Dec; 46(6):100866. PubMed ID: 36179388
[TBL] [Abstract][Full Text] [Related]
20. BMP signalling in human fetal ovary somatic cells is modulated in a gene-specific fashion by GREM1 and GREM2.
Bayne RA; Donnachie DJ; Kinnell HL; Childs AJ; Anderson RA
Mol Hum Reprod; 2016 Sep; 22(9):622-33. PubMed ID: 27385727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
